Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | HTT | P42858 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1707006 | 0.82 | L3MBTL1 (0.47) | ALDH1A1L3MBTL1MAPTKDM4ETSHR | |
| SCHEMBL3067955 | 0.81 | MAPK1 (0.38) | ALDH1A1KMT2A | |
| SCHEMBL13484002 | 0.80 | L3MBTL1 (0.46) | ALDH1A1L3MBTL1MAPTKDM4ETSHR | |
| SCHEMBL1646807 | 0.80 | ESR1 (0.34) | ALDH1A1TSHR | |
| SCHEMBL9874577 | 0.80 | ALDH1A1 (0.52) | ALDH1A1L3MBTL1MAPTKDM4ETSHR | |
| SCHEMBL545215 | 0.78 | L3MBTL1 (0.44) | ALDH1A1L3MBTL1MAPTKDM4ETSHR | |
| SCHEMBL18567172 | 0.77 | JAK2 (0.37) | ALDH1A1CYP2C9 | |
| SCHEMBL17299354 | 0.76 | HDAC4 (0.39) | ALDH1A1L3MBTL1HTTLMNACYP3A4 | |
| SCHEMBL18408453 | 0.76 | ACHE (0.55) | ALDH1A1L3MBTL1MAPTKDM4ETSHR | |
| SCHEMBL4880904 | 0.74 | L3MBTL1 (0.49) | ALDH1A1L3MBTL1MAPTKDM4ETSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11753497-B2 | Photocurable composition | CANON KABUSHIKI KAISHA (JP) | 2023-09-12 | — | — | US | disclosed |
| US-10023747-B2 | Active energy ray curable aqueous emulsions | ALLNEX BELGIUM S.A. (BE) | 2018-07-17 | — | — | US | disclosed |
| US-9796842-B2 | Epoxy functional polystyrene for enhanced PLA miscibility | FINA TECHNOLOGY, INC. (US) | 2017-10-24 | — | — | US | disclosed |
| US-8785627-B2 | Copolymerizable methine and anthraquinone compounds and articles containing them | Abbott Medical Optics Inc. (US) | 2014-07-22 | — | — | US | disclosed |
| US-8501890-B2 | Copolymerizable methine and anthraquinone compounds and articles containing them | Abbott Medical Optics Inc. (US) | 2013-08-06 | — | — | US | disclosed |
| US-20130018159-A1 | COPOLYMERIZABLE METHINE AND ANTHRAQUINONE COMPOUNDS AND ARTICLES CONTAINING THEM | Abbott Medical Optics Inc. (US) | 2013-01-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130018159-A1 | COPOLYMERIZABLE METHINE AND ANTHRAQUINONE COMPOUNDS AND ARTICLES CONTAINING THEM | CRY1, AAAS, CYBA | ALDH1A1 1377/4885L3MBTL1 4426/4885MAPT 580/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.